Free Trial

Neurocrine Biosciences (NBIX) Insider Trading & Ownership

Neurocrine Biosciences logo
$125.69 +0.27 (+0.22%)
As of 06/30/2025 04:00 PM Eastern

Neurocrine Biosciences (NASDAQ:NBIX) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
4.30%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
8
Amount Of
Insider Selling
(Last 12 Months)
$49.49M
Get NBIX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Neurocrine Biosciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

NBIX Insider Buying and Selling by Quarter

Neurocrine Biosciences Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/27/2025Kevin Charles GormanDirectorSell9,613$120.38$1,157,212.94  
5/5/2025William H RastetterDirectorSell30,000$110.20$3,306,000.00  
2/13/2025Julie CookeInsiderSell1,551$116.78$181,125.78  
2/13/2025Kevin Charles GormanDirectorSell5,844$116.69$681,936.36  
2/13/2025Matt AbernethyCFOSell2,558$116.86$298,927.88  
2/10/2025Julie CookeInsiderSell700$118.28$82,796.00  
2/10/2025Kevin Charles GormanDirectorSell2,274$118.37$269,173.38  
2/10/2025Kyle GanoCEOSell980$118.39$116,022.20  
2/3/2025Ingrid DelaetInsiderSell623$149.29$93,007.67  
1/31/2025Julie CookeInsiderSell1,740$152.89$266,028.60  
1/31/2025Kevin Charles GormanDirectorSell2,707$152.92$413,954.44  
1/31/2025Kyle GanoCEOSell1,541$152.87$235,572.67  
1/31/2025Matt AbernethyCFOSell1,283$152.87$196,132.21  
1/27/2025Kevin Charles GormanDirectorSell146,105$149.46$21,836,853.30  
1/15/2025Kyle GanoCEOSell65,000$141.50$9,197,500.00  
12/31/2024Ingrid DelaetInsiderSell272$138.10$37,563.20  
12/17/2024Ingrid DelaetInsiderSell1,091$135.00$147,285.00  
11/29/2024Jude OnyiaInsiderSell2,331$126.29$294,381.99  
8/15/2024William H RastetterDirectorSell14,250$146.69$2,090,332.50  
8/13/2024Gary A LyonsDirectorSell11,570$150.43$1,740,475.10  
8/13/2024Ingrid DelaetInsiderSell7,143$150.10$1,072,164.30  
8/13/2024Matt AbernethyCFOSell14,100$150.38$2,120,358.00  
8/6/2024Ingrid DelaetInsiderSell273$147.70$40,322.10  
8/1/2024Julie CookeInsiderSell12,632$153.26$1,935,980.32  
7/16/2024Gary A LyonsDirectorSell930$150.03$139,527.90  
7/16/2024Julie CookeInsiderSell900$150.04$135,036.00  
7/1/2024Julie CookeInsiderSell10,000$140.19$1,401,900.00  
(Data available from 1/1/2013 forward)

NBIX Insider Trading Activity - Frequently Asked Questions

4.30% of Neurocrine Biosciences stock is owned by insiders. Learn more on NBIX's insider holdings.

The following insiders have sold NBIX shares in the last 24 months: Darin Lippoldt ($5,121,159.93), David W Boyer ($700,550.20), Eiry Roberts ($3,331,855.97), Eric Benevich ($13,096,428.48), Gary A Lyons ($5,284,628.00), George J. Morrow ($5,576,800.00), Ingrid Delaet ($2,624,921.77), Jude Onyia ($902,482.92), Julie Cooke ($4,094,273.02), Kevin Charles Gorman ($40,872,589.79), Kyle Gano ($19,409,344.87), Leslie V. Norwalk ($1,085,360.00), Matt Abernethy ($5,621,659.53), Richard F Pops ($2,239,135.00), Shalini Sharp ($156,941.40), Stephen A Sherwin ($5,338,400.00), and William H Rastetter ($6,848,287.18).

Insiders have sold a total of 900,151 Neurocrine Biosciences shares in the last 24 months for a total of $122,304,818.06 sold.



This page (NASDAQ:NBIX) was last updated on 7/1/2025 by MarketBeat.com Staff
From Our Partners